Steady state BE study dosing [Design Issues]

posted by dshah  – India, 2024-01-22 11:09 (510 d 14:35 ago) – Posting: # 23837
Views: 3,683

Hi NK!

❝ Kindly clarify, whether 2nd and 3rd dose on day 5 need to be administered or not? and sampling should be continued for 24 hours?


So you are asking for protocol preparation consideration. The study is in healthy volunteers- so I believe that AUC0-t/AUC0-inf>=0.8 also needs to be followed, so consider sampling accordingly.

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
15 visitors (0 registered, 15 guests [including 13 identified bots]).
Forum time: 02:44 CEST (Europe/Vienna)

Law is mind without reason.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5